Ozanimod is an immunomodulatory compound that acts as a sphingosine-1-phosphate receptor agonist. It is used as an active pharmaceutical ingredient in medications for relapsing multiple sclerosis and ulcerative colitis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1306760-87-1
Ozanimod hydrochloride
pharmaceutical raw material
Dorzolamide hydrochloride
pharmaceutical raw material
Sodium picosulfate monohydrate
pharmaceutical raw material
Entacapone
pharmaceutical raw material
Spiroalmotriptan
pharmaceutical raw material
5-[3-[(1S)-1-(2-hydroxyethylamino)-2,3-dihydro-1H-inden-4-yl]-1,2,4-oxadiazol-5-yl]-2-propan-2-yloxybenzonitrile
XRVDGNKRPOAQTN-FQEVSTJZSA-N
CC(C)OC1=C(C=C(C=C1)C2=NC(=NO2)C3=C4CC[C@@H](C4=CC=C3)NCCO)C#N